SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-025176
Filing Date
2017-04-04
Accepted
2017-04-04 17:40:41
Documents
2
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2185
2 POA DOCUMENT poa.txt EX-24.3_716543 3596
  Complete submission text file 0001209191-17-025176.txt   7345
Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Cascadian Therapeutics, Inc. (Issuer) CIK: 0001412067 (see all company filings)

IRS No.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 307 WESTLAKE AVE. NORTH, STE 300 SEATTLE WA 98109
Business Address
Azelby Robert (Reporting) CIK: 0001656998 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33882 | Film No.: 17739912